NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
Clinical Trials
9 trialsNCT02583828 2024-02-07
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients
Capital Medical University
Phase NA Completed
NCT06235931 2024-02-01
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Second Affiliated Hospital of Soochow University
Phase NA Recruiting
NCT02701348 2021-08-06
BARONET
NHS Tayside
Phase NA Completed
NCT01669343 2021-05-13
Aromatase Inhibitor Host Factors Study
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT01153672 2019-09-06
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Phase NA Completed
NCT02010021 2019-01-17
Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT00114270 2013-03-26
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
National Cancer Institute (NCI)
Phase NA Completed